Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Antonio Broncano-Lavado"'
Autor:
Sergio Buenestado-Serrano, Miguel Martínez-Lirola, Marta Herranz-Martín, Jaime Esteban, Antonio Broncano-Lavado, Andrea Molero-Salinas, Amadeo Sanz-Pérez, Jesús Blázquez, Alba Ruedas-López, Carlos Toro, Paula López-Roa, Diego Domingo, Ester Zamarrón, María Jesús Ruiz Serrano, Patricia Muñoz, Laura Pérez-Lago, Darío García de Viedma
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-11 (2024)
Abstract Mycobacterium abscessus is an opportunistic, extensively drug-resistant non-tuberculous mycobacterium. Few genomic studies consider its diversity in persistent infections. Our aim was to characterize microevolution/reinfection events in pers
Externí odkaz:
https://doaj.org/article/b97c463e56e54a7597c9d25de9fa3aa6
Autor:
Alba Ruedas-López, Marta Tato, Antonio Broncano-Lavado, Jaime Esteban, María Jesús Ruiz-Serrano, María Sánchez-Cueto, Carlos Toro, Diego Domingo, Juana Cacho, Laura Barrado, Paula López-Roa
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 3 (2023)
ABSTRACT Mycobacterium abscessus (MABS) is the most pathogenic and drug-resistant rapidly growing mycobacteria. However, studies on MABS epidemiology, especially those focusing on subspecies level, are scarce. We aimed to determine MABS subspecies di
Externí odkaz:
https://doaj.org/article/012e33b558184547a92a075639fb3da9
Autor:
Guillermo Santamaría-Corral, Abrar Senhaji-Kacha, Antonio Broncano-Lavado, Jaime Esteban, Meritxell García-Quintanilla
Publikováno v:
Antibiotics, Vol 12, Iss 7, p 1089 (2023)
Phage therapy is an alternative therapy that is being used as the last resource against infections caused by multidrug-resistant bacteria after the failure of standard treatments. Pseudomonas aeruginosa can cause pneumonia, septicemia, urinary tract,
Externí odkaz:
https://doaj.org/article/ef2ee4f89da5433fac06fbee8941dd55
Autor:
Antonio Broncano-Lavado, Abrar Senhaji-Kacha, Guillermo Santamaría-Corral, Jaime Esteban, Meritxell García-Quintanilla
Publikováno v:
Antibiotics, Vol 11, Iss 10, p 1322 (2022)
Mycobacterium abscessus complex is extremely difficult to treat. Intrinsic and acquired bacterial resistance makes this species one of the most challenging pathogens and treatments last from months to years, associated with potential risky antibiotic
Externí odkaz:
https://doaj.org/article/aab2504b0cbd4d7a98388cd640033985
Autor:
Antonio Broncano-Lavado, Guillermo Santamaría-Corral, Jaime Esteban, Meritxell García-Quintanilla
Publikováno v:
Antibiotics, Vol 10, Iss 6, p 672 (2021)
The increase of multiresistance in bacteria and the shortage of new antibiotics in the market is becoming a major public health concern. The World Health Organization (WHO) has declared critical priority to develop new antimicrobials against three ty
Externí odkaz:
https://doaj.org/article/a3ac2496faf5498da53dffa706b83a8f
Autor:
Antonio Broncano-Lavado, Laura Barrado, Paula Lopez-Roa, Juana Cacho, Diego Domingo, Sara Hernandez, Jesus Garcia-Martinez, Maria Rosario Millan, Elisa Perez-Cecilia, Maria-Jesus Ruiz-Serrano, Santiago Salso, Maria Simon, Marta Tato, Carlos Toro, Jose F. Valverde-Canovas, Jaime Esteban
Publikováno v:
Journal of Clinical Microbiology. 61
Nontuberculous mycobacteria (NTM) are gaining interest with the increased number of infected patients. NTM Elite agar is designed specifically for the isolation of NTM without the decontamination step.
Autor:
María Jesús Rodríguez Nieto, Marta Lopez de las Heras, Silvia Calpena Martínez, Sarah Heili-Frades, Irene Carrillo Acosta, Aws Waleed Mohammed Al-Hayani, Laura Prieto-Pérez, Alba Naya, Javier Martinez, Miguel Ángel Piris Pinilla, Alicia Macias Valcayo, Marcel Jose Rodriguez Guzman, Ricardo Fernández Roblas, Miguel de Górgolas Hernández-Mora, Felipe Villar Álvarez, Alfonso Cabello Úbeda, José Fortes Alen, Pilar Carballosa, B. Alvarez, Fredeswinda Romero Bueno, Germán Peces-Barba Romero, Olga Sánchez Pernaute, Itziar Fernández Ormaechea, Marina Castellanos Gonzalez, Farah Ezzine, Antonio Broncano Lavado, Marta Martin Garcia, Ana Cordero Guijarro
Publikováno v:
International Journal of Infectious Diseases
International Journal of Infectious Diseases, Vol 102, Iss, Pp 303-309 (2021)
International Journal of Infectious Diseases, Vol 102, Iss, Pp 303-309 (2021)
Graphical abstract
Highlights • The survival rate is high (94% vs 72%) if tocilizumab is administered with a FiO2 ≤ 0.5%. • There are very limited side effects and secondary infections. • A significant decrease in the median serum ferrit
Highlights • The survival rate is high (94% vs 72%) if tocilizumab is administered with a FiO2 ≤ 0.5%. • There are very limited side effects and secondary infections. • A significant decrease in the median serum ferrit
Autor:
Jaime Esteban, Guillermo Santamaría-Corral, Antonio Broncano-Lavado, Meritxell Garcia-Quintanilla
Publikováno v:
Antibiotics, Vol 10, Iss 672, p 672 (2021)
Antibiotics
Antibiotics
The increase of multiresistance in bacteria and the shortage of new antibiotics in the market is becoming a major public health concern. The World Health Organization (WHO) has declared critical priority to develop new antimicrobials against three ty
Autor:
Miguel Górgolas Hernández-Mora, Alfonso Cabello Úbeda, Laura Prieto-Pérez, Felipe Villar Álvarez, Beatriz Álvarez Álvarez, María Jesús Rodríguez Nieto, Irene Carrillo Acosta, Itziar Fernández Ormaechea, Aws Waleed Mohammed Al-Hayani, Pilar Carballosa, Silvia Calpena Martínez, Farah Ezzine, Marina Castellanos González, Alba Naya, Marta López De Las Heras, Marcel José Rodríguez Guzmán, Ana Cordero Guijarro, Antonio Broncano Lavado, Alicia Macías Valcayo, Marta Martín García, Javier Bécares Martínez, Ricardo Fernández Roblas, Miguel Ángel Piris Pinilla, José Fortes Alen, Olga Sánchez Pernaute, Fredeswinda Romero Bueno, Sarah Heili-Frades, Germán Peces-Barba Romero
Publikováno v:
International Journal of Infectious Diseases, Vol 102, Iss , Pp 303-309 (2021)
Introduction: Tocilizumab (TCZ) is an interleukin-6 receptor antagonist, which has been used for the treatment of severe SARS-CoV-2 pneumonia (SSP), which aims to ameliorate the cytokine release syndrome (CRS) induced acute respiratory distress syndr
Externí odkaz:
https://doaj.org/article/2aae212706174c78b0f4443668f39cdb